ANTX
AN2 Therapeutics Inc
4.90$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | |
| – | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | |
| 0.56 | 0.50 | 0.49 | 0.41 | 0.28 | 0.18 | 0.26 | 0.11 | 0.23 | 0.23 | 0.20 | 0.13 | 0.60 | |
| 0.15 | 0.13 | 0.12 | 0.13 | 0.12 | 0.11 | 0.13 | 0.13 | 0.10 | 0.08 | 0.11 | 0.06 | 0.27 | |
| 0.71 | 0.63 | 0.61 | 0.53 | 0.47 | 0.29 | 0.38 | 0.24 | 0.33 | 0.31 | 0.31 | 0.20 | 0.87 | |
| -0.71 | -0.63 | -0.61 | -0.53 | -0.47 | -0.29 | -0.38 | -0.24 | -0.33 | -0.31 | -0.31 | -0.20 | -0.87 | |
| – | 0.02 | 0.02 | – | – | – | – | – | – | – | – | – | – | |
| -0.65 | -0.57 | -0.56 | -0.48 | -0.43 | -0.25 | -0.35 | -0.21 | -0.31 | -0.29 | -0.29 | -0.18 | -0.81 | |
| 0.00 | 0.00 | -0.61 | -0.53 | – | – | – | – | – | – | – | – | – | |
| -0.65 | -0.57 | -0.56 | -0.48 | -0.43 | -0.25 | -0.35 | -0.21 | -0.31 | -0.29 | -0.29 | -0.18 | -0.81 | |
| 0.06 | -0.55 | -0.56 | 0.37 | -0.39 | -0.25 | -0.35 | -0.21 | -0.31 | -0.33 | -0.29 | -0.18 | -0.84 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.